Market Place
Sourcing Support
Teva Pharms` Generic Dextroamp Saccharate Receives Approval in the U.S.
31 Jan 2022 //
FDA
Teva Pharms` Generic Sofosbuvir Receives Approval in the U.S.
27 Jan 2022 //
FDA
Malaysia set to become Hepatitis C treatment hub of Asia
16 Nov 2021 //
BIOSPECTRUMASIA
NPPA refuses Cipla’s application for discontinuation of four HIV drugs
15 Sep 2021 //
PHARMABIZ
U.S. FDA Approves New Formulation of Epclusa
10 Jun 2021 //
BUSINESSWIRE
FDA approves new formulation Gilead`s Epclusa for Kids ages 3 and older with HCV
10 Jun 2021 //
SEEKING ALPHA
EU OKs paediatric use of Gilead`s Epclusa
01 Sep 2020 //
PHARMATIMES
Gilead Announces Presentation of More Than 40 Abstracts Extensive Liver Disease
25 Aug 2020 //
PRESS RELEASE
Soaring drug prices could bar access to future coronavirus treatments
11 May 2020 //
THEGUARDIAN
FDA OKs Gilead’s paediatric hep C drug
20 Mar 2020 //
PHARMATIMES
FDA OKs Gilead’s paediatric hep C drug
20 Mar 2020 //
PHARMA TIMES
U.S. Food And Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir
19 Mar 2020 //
BUSINESSWIRE
European regulators expand use of AbbVie`s two-month hep C regimen
07 Mar 2020 //
ENDPTS
China National Medical Products Administration Approves Vosevi
20 Dec 2019 //
BUSINESSWIRE
Regulatory barriers limit alternative state drug payment models
18 Sep 2019 //
BIOSPAHRMADIVE
The Biopharmaceutical Cartel And High Drug Prices
10 Apr 2019 //
FORBES
Specialty drug costs skyrocketed to $32.8B in Medicare Part D in 2015
22 Mar 2019 //
HEALTHCARE DIVE
Gilead airs first ads for hep C brand Epclusa
05 Feb 2019 //
FIERCE PHARMA
NHS England sees off AbbVie`s Hep C legal challenge
22 Jan 2019 //
PM LIVE
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Epclusa®
08 Jan 2019 //
PRESS RELEASE
Supreme Court rebuffs appeals from Merck, Gilead in 2 high-profile drug battles
08 Jan 2019 //
FIERCE PHARMA
EEPI`s sofosbuvir prequalified
18 Dec 2018 //
EXTRANET
What do Martin Shkreli, Gilead and Takeda have in common?
06 Dec 2018 //
ENDPTS
Express Scripts plans `Flex` formulary focused on authorized generics
14 Nov 2018 //
BIOPHARMA DIVE
Merck asks SCOTUS for its $200M in Gilead patent dues
26 Sep 2018 //
FIERCE PHARMA
AbbVie`s facing kickbacks scrutiny with Biogen, Sanofi, Gilead
26 Sep 2018 //
FIERCE PHARMA
Brazil court strips Gilead of hepatitis C drug patent
25 Sep 2018 //
REUTERS
FDA Issues 54 New and Revised Product-Specific Guidances
13 Sep 2018 //
RAPS
AbbVie surprised investors with its hepatitis C success. Will it last?
03 Aug 2018 //
BIOPHARMA DIVE
Gilead`s top execs Milligan and Martin stepping down
26 Jul 2018 //
FIERCE PHARMA
PTAB shoots down tenth I-MAK Gilead challenge
24 Jul 2018 //
LIFESCIENCESPREVIEW
Two pre-grant patent oppositions filed on Gilead’s Hepatitis C medicines
09 Jul 2018 //
HINDU BUSINESS LINE
Roche stakes claim on Eli Lilly’s psoriasis med Taltz
06 Jul 2018 //
FIERCE PHARMA
Natco Pharma launches Hepatitis C drug in India
03 Jul 2018 //
ECONOMIC TIMES
Hookipa Biotech and Gilead Ink Deal to Develop HIV and Hepatitis B Therapies
05 Jun 2018 //
BIOSPACE
Enyo Pharma raises $47M to bring hepatitis B, NASH drug to phase 2
04 Jun 2018 //
FIERCE PHARMA
Enforcement Report - Week of May 16, 2018
16 May 2018 //
FDA
Ascletis files for Hong Kong IPO
08 May 2018 //
FIERCE BIOTECH
Sovaldi® (Sofosbuvir): Gilead Sciences v. Teva Pharmaceuticals USA
26 Mar 2018 //
PATENT LITIGATION
HHS is urged to investigate a Gilead hepatitis C patent for failing
15 Mar 2018 //
STATNEWS
Sovaldi® (Sofosbuvir) : Gilead Sciences, v. Natco Pharma Limited
14 Mar 2018 //
PATENT LITIGATION
Bye-bye, solo Express Scripts: What does the Cigna buyout mean for pharma?
08 Mar 2018 //
FIERCE PHARMA
FDA Confirms Paragraph IV Patent Challenge of Sovaldi (Sofosbuvir ) Tablets
15 Feb 2018 //
FDA
Sofosbuvir found to be effective against Zika virus
29 Jan 2018 //
EU PHARMACEUTICAL
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
06 Jan 2018 //
FIERCE PHARMA
I-MAK files 2 new US patent challenges on Gilead’s hepatitis C portfolio
07 Dec 2017 //
PHARMABIZ
Gilead prices hepatitis C giant Sovaldi in China at one-fifth the U.S. price
29 Nov 2017 //
FIERCE PHARMA
Mylan Receives WHO Prequalification for Generic Sovaldi®
26 Jul 2017 //
Gilead gets its go-ahead for blockbuster hopeful Vosevi
20 Jul 2017 //
FIERCE PHARMA
When science is not enough
09 May 2017 //
PMLIVE
Hetero gets DCGI nod for generic chronic hepatitis C drug
05 May 2017 //
ECONOMIC TIMES
Gilead (GILD) HCV Drugs Gets FDA Nod for Label Expansion
11 Apr 2017 //
NASDAQ
Japan seeks hefty cut to blockbuster Opdivo price
18 Oct 2016 //
FIERCE PHARMA
Gilead withdraw writ petition supporting consolidate hearing over patent right
16 May 2016 //
ECONOMIC TIMES
Government`s patent grant to Gilead challenged in Delhi High Court
16 May 2016 //
ECONOMIC TIMES
Patent not to affect hepatitis C drug price in India: Gilead Sciences Inc
12 May 2016 //
ECONOMIC TIMES
Gilead`s $1,000 pill gets patent in India
10 May 2016 //
ET HEALTHWORLD
Gilead Judge Re-Opens Case Amid Claim Merck Scientist Lied
03 May 2016 //
BLOOMBERG
